Tatiana G. Sedova
Tatiana G. Sedova has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Vladimir D. Elkin
E.A. Vagner Perm State Medical University
8 shared publications - A. A. Zhukova
Ye.A. Vagner Perm State Medical University
4 shared publications - Marina Y. Kobernik
Ye.A. Vagner Perm State Medical University
4 shared publications - Albina Nikolaevna Khlebnikova
Moscow Regional Research Clinical Institute named after M.F. Vladimirsky
3 shared publications - E.V. Plotnikova2 shared publications
- Elena Vladimirovna Selezneva
Moscow Regional Research and Clinical Institute (MONIKI)
2 shared publications
Latest Publications
- 7 November 2026
- Published by ECO-Vector LLC (Publications) in Perm Medical Journal
- Vol. 43 (5) , 113-123
Clinical and epidemiological features of potentially malignant epithelial neoplasms of the skin in the population of Perm
Оbjective. To analyze the clinical and epidemiological features of epithelial precancerous skin tumors among the population of Perm. Materials and methods. Using a total sampling method, a retrospective analysis of the initially registered incidence of epithelial precancerous skin tumors in the population of Perm for 2005-2020 was carried out, assessing long-term trends in incidence, structure by diagnosis, age and gender. The study analyzed data from the accounting and reporting documentation of the State Budgetary Healthcare Institution of Perm Krai "Regional Clinical Dermatovenereological Dispensary" and the State Budgetary Healthcare Institution of Perm Krai "Perm Regional Oncology Dispensary" (outpatient cards, medical histories, protocols of diagnostic biopsies, data from the regional information and analytical system "ProMed", data from dermato-oncological diagnostic appointments) of 2,766 patients with precancerous skin neoplasms. Results. During the period 2005–2020, precancerous neoplasms were registered in 2,766 patients (25.4 %) among epithelial skin tumors (10,879 patients). The long-term average incidence rate of precancerous tumors was 16.38 ± 2.49 per 100,000 population. The maximum incidence rate of epithelial precancerous skin tumors was found in the age group of 70 years and older – 907.84 ± 56.78 per 100,000 population. The predominant proportion of precancerous dermatoses (87.17 %) was caused by external factors, of which actinic keratosis accounted for a high proportion (45.5 %), with a predominance of females – in 69.7 % of cases. The long-term average incidence rate of precancerous tumors caused by external factors and actinic keratosis was 14.28 ± 2.33 and 6.49 ± 0.26 per 100,000 population, respectively. High incidence rates of actinic keratosis were established in the age groups 60–69 years – 307.79 ± 30.70 and 70 years and older – 315.36 ± 33.57 per 100,000 population in the respective age groups. Conclusions. A tendency towards stabilization of the long-term dynamics of the incidence of epithelial precancerous skin tumors, precancerous dermatoses caused by exposure to external factors, and actinic keratosis in the population of Perm for 2005–2020 was established. The incidence of precancerous skin tumors and dermatoses caused by exposure to external factors among men statistically significantly exceeded the registered incidence rate among women. On the contrary, the total incidence of actinic keratosis in females was statistically significantly higher than that in men. High levels of incidence of precancerous skin tumors in the population of Perm were revealed in the age groups 60–69 years and 70 years and older.
- 7 November 2026
- Published by ECO-Vector LLC (Publications) in Perm Medical Journal
- Vol. 43 (5) , 113-123
Clinical and epidemiological features of potentially malignant epithelial neoplasms of the skin in the population of Perm
Оbjective. To analyze the clinical and epidemiological features of epithelial precancerous skin tumors among the population of Perm. Materials and methods. Using a total sampling method, a retrospective analysis of the initially registered incidence of epithelial precancerous skin tumors in the population of Perm for 2005-2020 was carried out, assessing long-term trends in incidence, structure by diagnosis, age and gender. The study analyzed data from the accounting and reporting documentation of the State Budgetary Healthcare Institution of Perm Krai "Regional Clinical Dermatovenereological Dispensary" and the State Budgetary Healthcare Institution of Perm Krai "Perm Regional Oncology Dispensary" (outpatient cards, medical histories, protocols of diagnostic biopsies, data from the regional information and analytical system "ProMed", data from dermato-oncological diagnostic appointments) of 2,766 patients with precancerous skin neoplasms. Results. During the period 2005–2020, precancerous neoplasms were registered in 2,766 patients (25.4 %) among epithelial skin tumors (10,879 patients). The long-term average incidence rate of precancerous tumors was 16.38 ± 2.49 per 100,000 population. The maximum incidence rate of epithelial precancerous skin tumors was found in the age group of 70 years and older – 907.84 ± 56.78 per 100,000 population. The predominant proportion of precancerous dermatoses (87.17 %) was caused by external factors, of which actinic keratosis accounted for a high proportion (45.5 %), with a predominance of females – in 69.7 % of cases. The long-term average incidence rate of precancerous tumors caused by external factors and actinic keratosis was 14.28 ± 2.33 and 6.49 ± 0.26 per 100,000 population, respectively. High incidence rates of actinic keratosis were established in the age groups 60–69 years – 307.79 ± 30.70 and 70 years and older – 315.36 ± 33.57 per 100,000 population in the respective age groups. Conclusions. A tendency towards stabilization of the long-term dynamics of the incidence of epithelial precancerous skin tumors, precancerous dermatoses caused by exposure to external factors, and actinic keratosis in the population of Perm for 2005–2020 was established. The incidence of precancerous skin tumors and dermatoses caused by exposure to external factors among men statistically significantly exceeded the registered incidence rate among women. On the contrary, the total incidence of actinic keratosis in females was statistically significantly higher than that in men. High levels of incidence of precancerous skin tumors in the population of Perm were revealed in the age groups 60–69 years and 70 years and older.
- Open Access
- 3 March 2026
- Published by ECO-Vector LLC (Publications) in Perm Medical Journal
- Vol. 43 (1) , 5-20
Post-COVOID pathomorphosis (nosomorphosis) of chronic dermatoses. Literature review and clinical case reports
The COVID-19 pandemic has significantly influenced the course and clinical presentation of skin diseases. Literature data indicate frequent lesions of the mucous membranes, skin, and its adnexa following the novel coronavirus infection caused by SARS-CoV-2. The proportion of dermatoses associated with COVID-19 among infected patients reaches 20.4 %. Based on the time of their development, skin lesions associated with coronavirus infection, are classified as early (acute), observed, within 2 to 4 weeks. These include cutaneous angiitis, morbilliform, papulosquamous, and papulovesicular rashes, drug eruptions, urticaria, and factitial lesions. These dermatoses result from the direct effect of SARS-CoV-2, its toxins and metabolites on the skin and mucous membranes and/or from a concomitant drug-induced toxic-allergic reaction. Late (chronic) skin lesions develop from 1 month to 1 year after novel coronavirus infection or within 4 weeks after vaccination. Late skin diseases exacerbated by SARS-CoV-2 include papulosquamous dermatoses, post-COVID alopecia, allergic dermatoses, collagen vascular diseases, acneiform dermatoses, nail plate changes, erythema, bullous dermatoses, and psychogenic dermatoses. The pathological effect of SARS-CoV-2 in the late stages post-infection or post-vaccination is due to the affinity of certain keratinocyte structures for the virus. The virus enters the cell, stimulates T-lymphocyte activation, enhances T-helper cell proliferation, and hyperproduction of proinflammatory cytokines and antibodies. This leads to interleukins synthesis and hyperstimulation of tissue inflammation, impairing skin cell differentiation. A significant proportion of concomitant dermatoses and comorbid pathologies has been identified in patients with late skin lesions that developed within 1 year after SARS-CoV-2 or within 4 weeks after vaccination. Moderate to severe courses of post-COVID dermatoses and complicated clinical cases have been frequently reported. Most clinical observations have shown a predominance of widespread rashes, atypical localization, and atypical clinical presentations, with rare clinical variants being more common. Combinations of two and three dermatological nosologies in a single patient (multimorbidity) have been noted. Pathomorphosis (nosomorphosis) of papulosquamous and autoimmune skin diseases has been observed, manifesting as the evolution of one dermatosis into another.
- 3 March 2026
- Published by ECO-Vector LLC (Publications) in Perm Medical Journal
- Vol. 43 (1) , 5-20
Open AccessPost-COVOID pathomorphosis (nosomorphosis) of chronic dermatoses. Literature review and clinical case reports
The COVID-19 pandemic has significantly influenced the course and clinical presentation of skin diseases. Literature data indicate frequent lesions of the mucous membranes, skin, and its adnexa following the novel coronavirus infection caused by SARS-CoV-2. The proportion of dermatoses associated with COVID-19 among infected patients reaches 20.4 %. Based on the time of their development, skin lesions associated with coronavirus infection, are classified as early (acute), observed, within 2 to 4 weeks. These include cutaneous angiitis, morbilliform, papulosquamous, and papulovesicular rashes, drug eruptions, urticaria, and factitial lesions. These dermatoses result from the direct effect of SARS-CoV-2, its toxins and metabolites on the skin and mucous membranes and/or from a concomitant drug-induced toxic-allergic reaction. Late (chronic) skin lesions develop from 1 month to 1 year after novel coronavirus infection or within 4 weeks after vaccination. Late skin diseases exacerbated by SARS-CoV-2 include papulosquamous dermatoses, post-COVID alopecia, allergic dermatoses, collagen vascular diseases, acneiform dermatoses, nail plate changes, erythema, bullous dermatoses, and psychogenic dermatoses. The pathological effect of SARS-CoV-2 in the late stages post-infection or post-vaccination is due to the affinity of certain keratinocyte structures for the virus. The virus enters the cell, stimulates T-lymphocyte activation, enhances T-helper cell proliferation, and hyperproduction of proinflammatory cytokines and antibodies. This leads to interleukins synthesis and hyperstimulation of tissue inflammation, impairing skin cell differentiation. A significant proportion of concomitant dermatoses and comorbid pathologies has been identified in patients with late skin lesions that developed within 1 year after SARS-CoV-2 or within 4 weeks after vaccination. Moderate to severe courses of post-COVID dermatoses and complicated clinical cases have been frequently reported. Most clinical observations have shown a predominance of widespread rashes, atypical localization, and atypical clinical presentations, with rare clinical variants being more common. Combinations of two and three dermatological nosologies in a single patient (multimorbidity) have been noted. Pathomorphosis (nosomorphosis) of papulosquamous and autoimmune skin diseases has been observed, manifesting as the evolution of one dermatosis into another.
- 25 February 2025
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 24 (1)
Clinical case of complete oculocerebrocutaneous syndrome (Delleman syndrome) in newborn child
Clinical observation of complete oculocerebrocutaneous syndrome in newborn boy is presented. Clinical symptoms of the disease were characterized by right-sided ophthalmological (lipodermoid of conjunctive and upper eyelid, congenital coloboma of iris and optic nerve head, cataract), cerebral (schizencephaly, lissencephaly, pachygyria, arachnoid cyst of posterior cranial fossa, seizures) and cutaneous (congenital alopecia areata, aplasia cutis, atrophic scars, skin atrophy foci) manifestations. Oculocerebrocutaneous syndrome (Delleman syndrome) is a rare genetic pathology, sporadically occurring at 1 case per 500 000 newborn boys. Diagnostic criteria for Delleman syndrome include triad of ophthalmological, cerebral and cutaneous manifestations: congenital abnormalities and malformation of the eyes and brain, tumors and hamartomas of the skin, localized predominantly on the left side of the head. Dysplasia of cerebral cortex, agenesis of the corpus callosum, cerebellar hypoplasia, intracranial cysts, porencephaly, lissencephaly, seizure syndrome manifestations, signs of the delayed psychomotor development are revealed in congenital brain pathology. The ophthalmological symptoms of Delleman syndrome include orbital cysts, anophthalmia or microphthalmia, epibulbar neoplasms and dermoids, cataract, eyelids ectropion, coloboma, glaucoma. Skin manifestations include hypoplasia and aplasia of the skin, periorbital soft fibromas, alopecia areata and totalis, hamartomas and neoplasms of the skin and its appendages, dermoid cysts, lipomatosis of the face and periorbital area, foci of skin hyperpigmentation and hypopigmentation. The peculiarity of the presented clinical case is the rare occurrence of oculocerebrocutaneous syndrome in practice of dermatovenerologists and doctors of other specialties.
- 25 February 2025
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 24 (1)
Clinical case of complete oculocerebrocutaneous syndrome (Delleman syndrome) in newborn child
Clinical observation of complete oculocerebrocutaneous syndrome in newborn boy is presented. Clinical symptoms of the disease were characterized by right-sided ophthalmological (lipodermoid of conjunctive and upper eyelid, congenital coloboma of iris and optic nerve head, cataract), cerebral (schizencephaly, lissencephaly, pachygyria, arachnoid cyst of posterior cranial fossa, seizures) and cutaneous (congenital alopecia areata, aplasia cutis, atrophic scars, skin atrophy foci) manifestations. Oculocerebrocutaneous syndrome (Delleman syndrome) is a rare genetic pathology, sporadically occurring at 1 case per 500 000 newborn boys. Diagnostic criteria for Delleman syndrome include triad of ophthalmological, cerebral and cutaneous manifestations: congenital abnormalities and malformation of the eyes and brain, tumors and hamartomas of the skin, localized predominantly on the left side of the head. Dysplasia of cerebral cortex, agenesis of the corpus callosum, cerebellar hypoplasia, intracranial cysts, porencephaly, lissencephaly, seizure syndrome manifestations, signs of the delayed psychomotor development are revealed in congenital brain pathology. The ophthalmological symptoms of Delleman syndrome include orbital cysts, anophthalmia or microphthalmia, epibulbar neoplasms and dermoids, cataract, eyelids ectropion, coloboma, glaucoma. Skin manifestations include hypoplasia and aplasia of the skin, periorbital soft fibromas, alopecia areata and totalis, hamartomas and neoplasms of the skin and its appendages, dermoid cysts, lipomatosis of the face and periorbital area, foci of skin hyperpigmentation and hypopigmentation. The peculiarity of the presented clinical case is the rare occurrence of oculocerebrocutaneous syndrome in practice of dermatovenerologists and doctors of other specialties.
- 18 April 2024
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 23 (2)
Molecular pathology of genes of epigenetic regulation in epithelial skin tumors
Deregulation of epigenetic mechanisms plays a role in the development of skin cancer. Detection of its causes in precancer and carcinomas will allow to expand the understanding of the interdependence of conditions and therapeutic targets. OBJECTIVE To determine the spectrum of somatic genes’ mutations of epigenetic regulators in epithelial skin tumors — basal cell carcinoma (BCC), squamous cell carcinoma (SCC) and actinic keratosis (AK). MATERIAL AND METHODS The study included 769 samples. High-throughput parallel sequencing of DNA was performed using 3 panels, including 5 genes — PIK3CA, CDKN2A, CDH1, TP53, PTEN and 25 chromatin remodeling genes. RESULTS In the internal cohort, alterations in KMT2D (47.0%), EZH2 (42.0%), TP53 (37.0%) and HDAC2 (32.0%) have been seen in BCC, in SCC — mutations in CDKN2A gene in 61.0%, in TP53 gene — in 56.0%, in EZH2 and PBRM1 genes — in 44.0% and 28.0%. In AK, mutations in PIK3CA and TP53 genes have been observed in 40.0% of cases. Mutations have been found in the genes of histone modifiers of «writers» type and cofactors of histone modifiers of «writers» type. In the internal sample, differences in mutation rates between AK and BCC (p-value 0.0001), AK and SCC (p-value 0.04) have been found. In the external cohort, a higher mutation rate in BCC compared to SCC was observed in chromatin remodeling genes, histone modification cofactors and histone modifiers of «erasers» type (p-value 0.01, 0.007 and 0.003 respectively). In AK more mutations were registered in the group of histone modifiers of «erasers» type in comparison with SCC (p-value 0.01). CONCLUSION The high rate of somatic mutations of different types of genes of epigenetic regulation and differences in the involvement of genes groups of epigenetic regulators between AK and SCC, AK and BCC were identified.
- 18 April 2024
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 23 (2)
Molecular pathology of genes of epigenetic regulation in epithelial skin tumors
Deregulation of epigenetic mechanisms plays a role in the development of skin cancer. Detection of its causes in precancer and carcinomas will allow to expand the understanding of the interdependence of conditions and therapeutic targets. OBJECTIVE To determine the spectrum of somatic genes’ mutations of epigenetic regulators in epithelial skin tumors — basal cell carcinoma (BCC), squamous cell carcinoma (SCC) and actinic keratosis (AK). MATERIAL AND METHODS The study included 769 samples. High-throughput parallel sequencing of DNA was performed using 3 panels, including 5 genes — PIK3CA, CDKN2A, CDH1, TP53, PTEN and 25 chromatin remodeling genes. RESULTS In the internal cohort, alterations in KMT2D (47.0%), EZH2 (42.0%), TP53 (37.0%) and HDAC2 (32.0%) have been seen in BCC, in SCC — mutations in CDKN2A gene in 61.0%, in TP53 gene — in 56.0%, in EZH2 and PBRM1 genes — in 44.0% and 28.0%. In AK, mutations in PIK3CA and TP53 genes have been observed in 40.0% of cases. Mutations have been found in the genes of histone modifiers of «writers» type and cofactors of histone modifiers of «writers» type. In the internal sample, differences in mutation rates between AK and BCC (p-value 0.0001), AK and SCC (p-value 0.04) have been found. In the external cohort, a higher mutation rate in BCC compared to SCC was observed in chromatin remodeling genes, histone modification cofactors and histone modifiers of «erasers» type (p-value 0.01, 0.007 and 0.003 respectively). In AK more mutations were registered in the group of histone modifiers of «erasers» type in comparison with SCC (p-value 0.01). CONCLUSION The high rate of somatic mutations of different types of genes of epigenetic regulation and differences in the involvement of genes groups of epigenetic regulators between AK and SCC, AK and BCC were identified.
- Open Access
- 17 May 2023
- Published by Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov in Vestnik dermatologii i venerologii
- Vol. 99 (2) , 80-86
Giant nodular basal cell skin cancer
The article presents clinical case report of primary giant nodular basal cell skin cancer in two patients at the age of 64 and 68 years and with disease duration of 20 and 15 years respectively. Psychological status of fear and anxiety are considered the main reasons for the late health encounter. The clinical picture of the case report was characterized by a slow long-term asymptomatic growth of solitary tumor-like mushroom-shaped nodes of stagnant pink color with a bumpy surface, densely elastic consistency, adherent to underlying soft tissues and sized 9.5 7.0 cm and 5.0 9.0 cm respectively. Giant basaliomas were located on the scalp in a woman and on the trunk skin in a man. The clinical tumors features are corresponded to those of a large conglomerated basal cell skin cancer. The article also presents a description of the clinical and dermatoscopic picture of giant nodular basaliomas. The patients underwent curative surgical excision of tumors with pathomorphological examination of the postoperative material. The histological picture of giant basal cell carcinoma in both cases is represented by tumors of a complex structure, namely a solid adenoid type with invasion into the reticular dermis and subcutaneous fat. The low biological potential of giant nodular basaliomas has been established.
- 17 May 2023
- Published by Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov in Vestnik dermatologii i venerologii
- Vol. 99 (2) , 80-86
Open AccessGiant nodular basal cell skin cancer
The article presents clinical case report of primary giant nodular basal cell skin cancer in two patients at the age of 64 and 68 years and with disease duration of 20 and 15 years respectively. Psychological status of fear and anxiety are considered the main reasons for the late health encounter. The clinical picture of the case report was characterized by a slow long-term asymptomatic growth of solitary tumor-like mushroom-shaped nodes of stagnant pink color with a bumpy surface, densely elastic consistency, adherent to underlying soft tissues and sized 9.5 7.0 cm and 5.0 9.0 cm respectively. Giant basaliomas were located on the scalp in a woman and on the trunk skin in a man. The clinical tumors features are corresponded to those of a large conglomerated basal cell skin cancer. The article also presents a description of the clinical and dermatoscopic picture of giant nodular basaliomas. The patients underwent curative surgical excision of tumors with pathomorphological examination of the postoperative material. The histological picture of giant basal cell carcinoma in both cases is represented by tumors of a complex structure, namely a solid adenoid type with invasion into the reticular dermis and subcutaneous fat. The low biological potential of giant nodular basaliomas has been established.
- 24 April 2023
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 22 (5)
Muir-Torre syndrome
The clinical case of Muir-Torre syndrome in a patient with multifocal synchronous basal cell skin cancer with sebaceous differentiation and endometrial cancer in a medical history, including clinical manifestations and dermatoscopic pattern features of sebaceous adenoma, epithelioma with sebaceous glandular differentiation and sebaceous glandular skin hyperplasia, which were confirmed by pathomorphological examination, is described. Muir-Torre syndrome is a rare genetic syndrome with autosomal dominant type of inheritance, characterized by a combination of multiple sebaceous neoplasms and oncopathology of visceral organs. The disease is found in patients over 50 years old, mainly in men. The etiology of syndrome is associated with mutations in the genes of DNA repair system leading to skin and visceral organs cancers. The dermatological spectrum of Muir-Torre syndrome is presented by benign and malignant skin cancers with sebaceous differentiation, namely adenoma, sebaceoma, superficial epithelioma, sebaceous carcinoma and basal cell cancer. Patients have a malignant cancers of visceral organs, namely colon, rectum, urogenital and bronchopulmonary systems, gastrointestinal and biliary tracts, mammary gland and blood system in addition to skin lesions. In most cases, skin symptoms of disease debut after visceral organs cancer detection. The diagnostic criterion of Muir—Torre syndrome is the association of multiple sebaceous glandular skin neoplasms with cancer of visceral organs. Additional clinical signs include sebaceous glandular hyperplasia of the skin. In case of evidence detection of skin lesions, a careful examination of patient must be done for the purpose of timely detection of visceral organs’ oncopathogy and medical and genetic consultation of both the patient and his close relatives.
- 24 April 2023
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 22 (5)
Muir-Torre syndrome
The clinical case of Muir-Torre syndrome in a patient with multifocal synchronous basal cell skin cancer with sebaceous differentiation and endometrial cancer in a medical history, including clinical manifestations and dermatoscopic pattern features of sebaceous adenoma, epithelioma with sebaceous glandular differentiation and sebaceous glandular skin hyperplasia, which were confirmed by pathomorphological examination, is described. Muir-Torre syndrome is a rare genetic syndrome with autosomal dominant type of inheritance, characterized by a combination of multiple sebaceous neoplasms and oncopathology of visceral organs. The disease is found in patients over 50 years old, mainly in men. The etiology of syndrome is associated with mutations in the genes of DNA repair system leading to skin and visceral organs cancers. The dermatological spectrum of Muir-Torre syndrome is presented by benign and malignant skin cancers with sebaceous differentiation, namely adenoma, sebaceoma, superficial epithelioma, sebaceous carcinoma and basal cell cancer. Patients have a malignant cancers of visceral organs, namely colon, rectum, urogenital and bronchopulmonary systems, gastrointestinal and biliary tracts, mammary gland and blood system in addition to skin lesions. In most cases, skin symptoms of disease debut after visceral organs cancer detection. The diagnostic criterion of Muir—Torre syndrome is the association of multiple sebaceous glandular skin neoplasms with cancer of visceral organs. Additional clinical signs include sebaceous glandular hyperplasia of the skin. In case of evidence detection of skin lesions, a careful examination of patient must be done for the purpose of timely detection of visceral organs’ oncopathogy and medical and genetic consultation of both the patient and his close relatives.
- 24 April 2023
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 22 (3)
Lupus-carcinoma in a patient with lupus tuberculosis
A case of lupus carcinoma in a patient with lupus tuberculosis is presented. Skin manifestations of tuberculosis, symptoms of «apple jelly» and Pospelov signs are described, and laboratory and instrumental tests are presented. The patient has clinical, dermatoscopic, and ultrasonographic signs of lupus carcinoma (infiltrating basal cell carcinoma of the skin) confirmed by cytological and pathological examination. Lupus-carcinoma is a rare and severe complication of chronic dermatoses with abnormal regeneration, particularly lupus tuberculous and erythematosus. Lupus-carcinoma occurs mainly in patients with lupus tuberculosis (0.5–4% of cases); the interval between the disease onset and verification of skin cancer can vary from 10 to 40 years or more. Risk factors for malignancy include a prolonged course of the underlying disease, mechanical and burn injury, occupational hazards, exposure to ionizing, ultraviolet or X-ray radiation, concomitant chronic inflammatory conditions, abnormal skin pigmentation, prolonged immunosuppression, age older than 40 years, male gender, types I and II of skin photosensitivity, personal and family oncological history. The clinical presentation of lupus carcinoma includes a predominantly solitary deep ulcer-infiltrating skin defect or ulcer-exophytic mass localized in lupus tuberculous or erythematosus lesions. Important clinical features of lupus carcinoma are the irregular shape and cartilaginous density of the mass, the absence of a skin pattern on the surface of the element, the presence of infiltrated, undermined, and roll-shaped edges with multiple telangiectasias, glomerated with adjacent tissues, increased bleeding tendency and soreness on palpation. The diagnosis of lupus carcinoma is verified by pathological examination of the biopsy specimen with histological signs of invasive squamous cell or infiltrating basal cell skin cancer.
- 24 April 2023
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 22 (3)
Lupus-carcinoma in a patient with lupus tuberculosis
A case of lupus carcinoma in a patient with lupus tuberculosis is presented. Skin manifestations of tuberculosis, symptoms of «apple jelly» and Pospelov signs are described, and laboratory and instrumental tests are presented. The patient has clinical, dermatoscopic, and ultrasonographic signs of lupus carcinoma (infiltrating basal cell carcinoma of the skin) confirmed by cytological and pathological examination. Lupus-carcinoma is a rare and severe complication of chronic dermatoses with abnormal regeneration, particularly lupus tuberculous and erythematosus. Lupus-carcinoma occurs mainly in patients with lupus tuberculosis (0.5–4% of cases); the interval between the disease onset and verification of skin cancer can vary from 10 to 40 years or more. Risk factors for malignancy include a prolonged course of the underlying disease, mechanical and burn injury, occupational hazards, exposure to ionizing, ultraviolet or X-ray radiation, concomitant chronic inflammatory conditions, abnormal skin pigmentation, prolonged immunosuppression, age older than 40 years, male gender, types I and II of skin photosensitivity, personal and family oncological history. The clinical presentation of lupus carcinoma includes a predominantly solitary deep ulcer-infiltrating skin defect or ulcer-exophytic mass localized in lupus tuberculous or erythematosus lesions. Important clinical features of lupus carcinoma are the irregular shape and cartilaginous density of the mass, the absence of a skin pattern on the surface of the element, the presence of infiltrated, undermined, and roll-shaped edges with multiple telangiectasias, glomerated with adjacent tissues, increased bleeding tendency and soreness on palpation. The diagnosis of lupus carcinoma is verified by pathological examination of the biopsy specimen with histological signs of invasive squamous cell or infiltrating basal cell skin cancer.
- 7 March 2023
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 22 (1)
Ultrasonographic features of superficial, nodular, and scleroderma-like basal cell carcinoma of the skin
АКТУАЛЬНОСТЬ Базально-клеточный рак (БКР) — наиболее часто встречающаяся злокачественная опухоль кожи. В настоящее время для неинвазивной диагностики БКР широко применяется высокочастотное ультразвуковое сканирование. Однако ультрасонографические особенности различных клинических форм опухоли изучены недостаточно. ЦЕЛЬ ИССЛЕДОВАНИЯ Изучить ультрасонографическую картину поверхностной, нодулярной и склеродермоподобной форм БКР с использованием высокочастотных датчиков 30 и 75 МГц и определить характерные для каждой формы признаки. МАТЕРИАЛ И МЕТОДЫ В исследование включены 88 больных. С помощью ультразвуковой системы высокого разрешения изучено 116 патологических участков. При глубине распространения очагов 1 мм и менее использовали датчик 75 МГц, >2 мм — 30 МГц. Измеряли толщину эпидермиса и дермы, глубину распространения опухолей в зонах интереса, а также эхогенность патологических очагов и дермы по их периферии. РЕЗУЛЬТАТЫ На сканограммах все клинические варианты БКР определялись в виде гипоэхогенных очагов. При этом поверхностный БКР имел продолговатую форму, хорошо визуализируемые границы и однородную структуру, нодулярный — округлые или овальные очертания, четкие края и диффузно-неоднородную структуру. Сканограммы склеродермоподобных базалиом были представлены гипоэхогенными образованиями 3 разновидностей: первая характеризовалась очагом округлой или неправильной формы с почкообразными отростками и размытыми границами, вторая — очагом полосовидной формы с нечеткими границами, третья — конгломератом из нескольких очагов вытянутой формы с четкими очертаниями, соединенных гиперэхогенными прослойками. Отмечено статистически значимое увеличение глубины распространения очагов нодулярной формы по сравнению с поверхностной и склеродермоподобной (Pp<0,05). Плотность гипоэхогенных участков и окружающей их дермы была максимальной в склеродермоподобных базалиомах.
- 7 March 2023
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 22 (1)
Ultrasonographic features of superficial, nodular, and scleroderma-like basal cell carcinoma of the skin
АКТУАЛЬНОСТЬ Базально-клеточный рак (БКР) — наиболее часто встречающаяся злокачественная опухоль кожи. В настоящее время для неинвазивной диагностики БКР широко применяется высокочастотное ультразвуковое сканирование. Однако ультрасонографические особенности различных клинических форм опухоли изучены недостаточно. ЦЕЛЬ ИССЛЕДОВАНИЯ Изучить ультрасонографическую картину поверхностной, нодулярной и склеродермоподобной форм БКР с использованием высокочастотных датчиков 30 и 75 МГц и определить характерные для каждой формы признаки. МАТЕРИАЛ И МЕТОДЫ В исследование включены 88 больных. С помощью ультразвуковой системы высокого разрешения изучено 116 патологических участков. При глубине распространения очагов 1 мм и менее использовали датчик 75 МГц, >2 мм — 30 МГц. Измеряли толщину эпидермиса и дермы, глубину распространения опухолей в зонах интереса, а также эхогенность патологических очагов и дермы по их периферии. РЕЗУЛЬТАТЫ На сканограммах все клинические варианты БКР определялись в виде гипоэхогенных очагов. При этом поверхностный БКР имел продолговатую форму, хорошо визуализируемые границы и однородную структуру, нодулярный — округлые или овальные очертания, четкие края и диффузно-неоднородную структуру. Сканограммы склеродермоподобных базалиом были представлены гипоэхогенными образованиями 3 разновидностей: первая характеризовалась очагом округлой или неправильной формы с почкообразными отростками и размытыми границами, вторая — очагом полосовидной формы с нечеткими границами, третья — конгломератом из нескольких очагов вытянутой формы с четкими очертаниями, соединенных гиперэхогенными прослойками. Отмечено статистически значимое увеличение глубины распространения очагов нодулярной формы по сравнению с поверхностной и склеродермоподобной (Pp<0,05). Плотность гипоэхогенных участков и окружающей их дермы была максимальной в склеродермоподобных базалиомах.
- Open Access
- 9 February 2023
- Published by Moscow Regional Research and Clinical Institute (MONIKI) in Almanac of Clinical Medicine
- Vol. 50 (7) , 455-461
Actinic keratosis as a predictor of primary multiple synchronous squamous cell skin cancer: a clinical case
We present a clinical case of a primary multiple synchronous highly differentiated keratinizing squamous cell skin cancer in an 84-year old patient with multiple actinic keratosis and actinic cheilitis. The clinical case is unique for the simultaneous development of primary multiple squamous cell carcinoma of the tip of the nose and the vermilion zone of the lower lip in a patient with a past occupational and solar burden, a light phenotype, and signs of chronic photo injury the skin. Clinical, dermatoscopic and sonographic signs of keratotic actinic keratosis were identified in the patient and confirmed by pathomorphological examination. The risk factors for malignant transformation of actinic keratosis were found, such as multiple efflorescences and a long disease history. The malignant transformation of the actinic areas manifested as rapidly progressive ulceration zones more than 1 cm in diameter, pronounced hyperkeratosis, inflammation and infiltration of the underlying tissues, increased bleeding and pain. It is to be underlined that definitive and differential diagnosis requires pathomorphological assessment of the skin biopsy sample. This clinical case indicates that patients with multiple foci of actinic keratosis should be under a lifelong follow-up by dermatovenereologists, with mandatory treatment and prevention measure.
- 9 February 2023
- Published by Moscow Regional Research and Clinical Institute (MONIKI) in Almanac of Clinical Medicine
- Vol. 50 (7) , 455-461
Open AccessActinic keratosis as a predictor of primary multiple synchronous squamous cell skin cancer: a clinical case
We present a clinical case of a primary multiple synchronous highly differentiated keratinizing squamous cell skin cancer in an 84-year old patient with multiple actinic keratosis and actinic cheilitis. The clinical case is unique for the simultaneous development of primary multiple squamous cell carcinoma of the tip of the nose and the vermilion zone of the lower lip in a patient with a past occupational and solar burden, a light phenotype, and signs of chronic photo injury the skin. Clinical, dermatoscopic and sonographic signs of keratotic actinic keratosis were identified in the patient and confirmed by pathomorphological examination. The risk factors for malignant transformation of actinic keratosis were found, such as multiple efflorescences and a long disease history. The malignant transformation of the actinic areas manifested as rapidly progressive ulceration zones more than 1 cm in diameter, pronounced hyperkeratosis, inflammation and infiltration of the underlying tissues, increased bleeding and pain. It is to be underlined that definitive and differential diagnosis requires pathomorphological assessment of the skin biopsy sample. This clinical case indicates that patients with multiple foci of actinic keratosis should be under a lifelong follow-up by dermatovenereologists, with mandatory treatment and prevention measure.
- 1 January 2022
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 21 (3) , 404
Botulinum toxins in cosmetology practice
В статье представлены краткая характеристика ботулинического токсина, история его применения в медицинской практике, приведены основные показания к использованию в настоящее время. Особое внимание уделено коррекции косметических недостатков лица: гиперфункциональных мимических морщин, изменения овала лица. Описана технология производства ботулинического токсина. Подробно изложен механизм его действия, заключающийся в блокаде нейромышечных связей с развитием функциональной денервации мышц, также отражен процесс реиннервации, который развивается благодаря процессу спраутинга. Рассмотрены сравнительная характеристика и фармакологические особенности основных препаратов ботулотоксина типа A; приведены сведения о ботулотоксинах других серотипов. Описаны клиническая эффективность и переносимость препаратов ботулотоксинов, их биологическая активность, длительность действия, абсолютные и относительные противопоказания к применению, а также побочные реакции, включая ботулинофилию и формирование «маски ботокса». Отмечено, что разные препараты ботулотоксинов не взаимозаменяемы, а рекомендации по подбору доз не могут основываться на каком-то единственном перерасчетном коэффициенте. Уделено внимание образованию антител к ботулотоксинам, оказывающим влияние на выраженность и время действия препаратов. Показано, что результат ботулинотерапии в большой степени зависит от правильного выполнения техники инъекций: определения оптимальной дозы ботулотоксина и выбора мышц-мишеней. Данные литературы свидетельствуют об эффективности и безопасности применения ботулотоксина для коррекции инволюционных изменений лица.
- 1 January 2022
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 21 (3) , 404
Botulinum toxins in cosmetology practice
В статье представлены краткая характеристика ботулинического токсина, история его применения в медицинской практике, приведены основные показания к использованию в настоящее время. Особое внимание уделено коррекции косметических недостатков лица: гиперфункциональных мимических морщин, изменения овала лица. Описана технология производства ботулинического токсина. Подробно изложен механизм его действия, заключающийся в блокаде нейромышечных связей с развитием функциональной денервации мышц, также отражен процесс реиннервации, который развивается благодаря процессу спраутинга. Рассмотрены сравнительная характеристика и фармакологические особенности основных препаратов ботулотоксина типа A; приведены сведения о ботулотоксинах других серотипов. Описаны клиническая эффективность и переносимость препаратов ботулотоксинов, их биологическая активность, длительность действия, абсолютные и относительные противопоказания к применению, а также побочные реакции, включая ботулинофилию и формирование «маски ботокса». Отмечено, что разные препараты ботулотоксинов не взаимозаменяемы, а рекомендации по подбору доз не могут основываться на каком-то единственном перерасчетном коэффициенте. Уделено внимание образованию антител к ботулотоксинам, оказывающим влияние на выраженность и время действия препаратов. Показано, что результат ботулинотерапии в большой степени зависит от правильного выполнения техники инъекций: определения оптимальной дозы ботулотоксина и выбора мышц-мишеней. Данные литературы свидетельствуют об эффективности и безопасности применения ботулотоксина для коррекции инволюционных изменений лица.